The Test
The PromarkerD test system is a blood test that assesses the risk of diabetic kidney disease in people with type 2 diabetes
A blood test for the prediction of diabetic kidney disease
PromarkerD can predict the onset of disease before clinical symptoms appear
Doctors can prescribe an early therapeutic treatment to slow or stop the onset of disease
Kidneys remain healthier for longer, saving healthcare expenses and improving quality of life for patients
How the PromarkerD test works
Blood sample
A sample is drawn at clinic or pathology laboratory
Biomarker analysis
Laboratory uses standard technology platform (immunoassay) to measure plasma protein biomarkers
PromarkerD hub software
Cloud-based algorithm calculates patient kidney disease risk score
Patient is classified as LOW RISK, MODERATE RISK, or HIGH RISK
Intervention plan
Clinician delivers results to patient
A personalised intervention/ management plan is created
Results & clinical intervention
Risk profile
Intervention
Recommended testing
Low risk
Low four-year risk of developing DKD
- Standard diabetes management
Every 4 years
Moderate risk
Moderate four-year risk of developing DKD
- More frequent monitoring
- Lifestyle optimization
- Avoidance of potentially nephrotoxic drugs
- Review of glycemic targets and non-glycemic risk factors
Every 2 years
High risk
High four-year risk of developing DKD
- Very close monitoring
- Intensive management strategies
- Utilization of therapeutic drugs
Immediate Action
Find out how PromarkerD can make a difference
Learn more about this novel blood test which may detect your risk of kidney disease early, before symptoms appear
